Charles River Laboratories International, Inc. (CRL)
291.50
-4.91
(-1.66%)
USD |
NYSE |
Aug 28, 16:00
291.40
-0.10
(-0.04%)
After-Hours: 20:00
Charles River Laboratories International Free Cash Flow : 370.60M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 370.60M |
| March 31, 2026 | 391.29M |
| December 31, 2025 | 518.49M |
| September 30, 2025 | 543.67M |
| June 30, 2025 | 578.50M |
| March 31, 2025 | 563.24M |
| December 31, 2024 | 501.61M |
| September 30, 2024 | 560.48M |
| June 30, 2024 | 486.92M |
| March 31, 2024 | 413.61M |
| December 31, 2023 | 365.37M |
| September 30, 2023 | 368.48M |
| June 30, 2023 | 289.37M |
| March 31, 2023 | 275.25M |
| December 31, 2022 | 294.91M |
| September 30, 2022 | 279.66M |
| June 30, 2022 | 338.46M |
| March 31, 2022 | 411.99M |
| December 31, 2021 | 532.03M |
| September 30, 2021 | 452.07M |
| June 30, 2021 | 484.00M |
| March 31, 2021 | 479.34M |
| December 31, 2020 | 380.02M |
| September 30, 2020 | 446.33M |
| June 30, 2020 | 415.90M |
| Date | Value |
|---|---|
| March 31, 2020 | 385.16M |
| December 31, 2019 | 340.42M |
| September 30, 2019 | 294.88M |
| June 30, 2019 | 269.00M |
| March 31, 2019 | 266.89M |
| December 31, 2018 | 301.09M |
| September 30, 2018 | 325.52M |
| June 30, 2018 | 268.19M |
| March 31, 2018 | 249.86M |
| December 31, 2017 | 235.64M |
| September 30, 2017 | 228.48M |
| June 30, 2017 | 251.05M |
| March 31, 2017 | 232.91M |
| December 31, 2016 | 245.09M |
| September 30, 2016 | 230.61M |
| June 30, 2016 | 248.41M |
| March 31, 2016 | 254.67M |
| December 31, 2015 | 224.98M |
| September 30, 2015 | 223.72M |
| June 30, 2015 | 203.32M |
| March 31, 2015 | 178.54M |
| December 31, 2014 | 195.21M |
| September 30, 2014 | 171.04M |
| June 30, 2014 | 172.10M |
| March 31, 2014 | 163.62M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| IQVIA Holdings, Inc. | 2.184B |
| Medpace Holdings, Inc. | 706.69M |
| Fortrea Holdings, Inc. | 196.00M |
| Avantor, Inc. | 454.70M |
| Champions Oncology, Inc. | -5.036M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 179.72M |
| Cash from Investing (Quarterly) | 28.10M |
| Cash from Financing (Quarterly) | -164.66M |
| Free Cash Flow Per Share (Quarterly) | 3.095 |
| Free Cash Flow to Equity (Quarterly) | 178.83M |
| Free Cash Flow to Firm (Quarterly) | 148.19M |
| Free Cash Flow Yield | 2.60% |